Click it and Unblock the Notifications
For Quick Alerts
For Daily Alerts
Just In
Don't Miss
-
Jos Buttler's Match-Winning Century Propels Him to Second Place for Most Centuries in IPL During KKR vs RR Encounter -
Dr Sarvepalli Radhakrishnan Death Anniversary: Profound And Inspiring Quotes For Students -
Rs 7/Share Dividend: May 3 Fixed As Record Date; Buy The Large Cap Stock To Be Eligible? -
Bade Miyan Chote Miyan Vs Maidaan Box Office Collection Day 6 -
UPSC Success Story: An IITian, A Government Job Holder at Railways, Quit the Job and Emerged as an IAS -
Jeep Compass Gets More Powerful 268.3bhp Turbo Petrol Engine – Check Out All The Details Here -
Redmi Pad SE With 90Hz Display Launching on April 23 in India; Could Be Priced for Less Than Rs 20,000 -
From Coconut Breaking on Head to Men Dressing as Women: 12 Unique Indian Rituals Explored
Suven Life signs with Eli Lilly for CNS Drug discovery
New Delhi, Mar 16 (UNI) Suven Life Sciences Ltd said it has signed an agreement with US based Eli Lilly to receive research funding as well as potential discovery and development milestone payments in the range of 19-23 million dollars per candidate.
The company will also receive potential royalties on net sales of any products that may be successfully commercialised.
The agreement is to collaborate on the pre-clinical research of molecules in the therapeutic area of central nervous system disorders (CNS).
As per the agreement, Suven will be responsible for discovery activities related to the identification and selection of clinical candidates in the area of CNS, in close association with Lilly.
UNI
BJR
SG
KN1422
Comments
Story first published: Sunday, March 16, 2008, 15:02 [IST]
